PTC Therapeutics Inc
F:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
F:BH3
|
US |
|
U
|
UniCredit SpA
XBER:CRIN
|
IT |
|
Alpha Services and Holdings SA
OTC:ALBKF
|
GR |
Multiples-Based Value
The Multiples-Based Value for
PTC Therapeutics Inc (BH3) under the Base Case is 64.56 EUR.
Compared with the current market price of 68.58 EUR, the stock appears
Overvalued by 6% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.